Effects of brain-derived neurotrophic factor-catecholamine-O- methyltransferase gene interaction on schizophrenic symptoms

NeuroReport

Volumn 19, Issue 11, 2008, Pages 1155-1158

  Han, Doug Hyun ^a   Park, Doo Byung ^a,b   Choi, Tae Young ^a   Joo, So Youn ^a   Lee, Mi Kyung ^b   Park, Bo Rae G ^b   Nishimura, Ryoji ^c   Chu, Chung Chou ^d   Renshaw, Perry F ^e  

^a Catholic University of Daegu   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c FUKUOKA UNIVERSITY   (Japan)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MCLEAN HOSPITAL   (United States)

Author keywords

Brain derived neurotrophic factor; Catecholamine O methyltransferase; Schizophrenia; Stroop color word test; Trail making test B

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DELUSION; FEMALE; GENE INTERACTION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSYCHOLOGIC TEST; READING; SCHIZOPHRENIA; WORD RECOGNITION; COGNITIVE DEFECT; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; COGNITION DISORDERS; DELUSIONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VARIATION (GENETICS); WORD ASSOCIATION TESTS;

EID: 49949105630     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32830867ad     Document Type: Article

References (25)

1. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112:257-269.
2. Ho BC, Andreasen NC, Dawson JD, Wassink TH. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007; 164:1890-1899.
3. Benton AL. Neuropsychological assessment. Annu Rev Psychol 1994; 45: 1-23.
4. Ollat H. Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil. J Neurol 1992; 239 (Suppl 1):S13-S16.
5. Nolan KA, Bilder RM, Lachman HM, Volavka J. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 2004; 161:359-361.
6. Deutch AY, Roth RH. Neurotransmitters. San Diego: Academic Press; 1999.
7. Han DH, Kee BS, Min KJ, Lee YS, Na C, Park DB, et al. Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 2006; 17:95-99.
8. Diamond A, Briand L, Fossella J, Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 2004; 161:125-132.
9. Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005; 76:99-125.
10. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350:230-232.
11. Martin-Iverson MT, Todd KG, Altar CA. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 1994; 14:1262-1270.
12. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006; 63:731-740.
13. Lang AH, Eerola O, Korpilahti P, Holopainen I, Salo S, Aaltonen O. Practical issues in the clinical application of mismatch negativity. Ear Hear 1995; 16:118-130.
14. Ruiz-Sanz JI, Aurrekoetxea I, Ruiz del Agua A, Ruiz-Larrea MB. Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR. Mol Cell Probes 2007; 21:202-207.
15. Andreasen NC. Modified Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa; 1984.
16. Andreasen NC. Modified Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1984.
17. Lyoo IK, Kwon JS, Ha KS. Development and standardization of computerized higher cortical function assessment for Korean adults. J Korean Neuropsychiatr Assoc 2002; 3:538-550.
18. De Chaldee M, Corbex M, Campion D, Jay M, Samolyk D, Petit M, et al. No evidence for linkage between COMT and schizophrenia in a French population. Psychiatry Res 2001; 102:87-90.
19. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Kinouchi S, et al. Interaction between catechol-O-methyltransferase (COMT) Val108/ 158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia. J Neural Transm 2007; 114:255-259.
20. Han DH, Park DB, Na C, Kee BS, Lee YS. Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes. Psychiatry Res 2004; 129:29-37.
21. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007; 17:165-170.
22. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 1997; 69:71-77.
23. Angelucci F, Ricci V, Pomponi M, Conte G, Mathe AA, Attilio Tonali P, et al. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol 2007; 21:820-825.
24. Buckley PF, Mahadik S, Pillai A, Terry A Jr. Neurotrophins and schizophrenia. Schizophr Res 2007; 94:1-11.
25. Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006; 59:673-680.